General Information on CeNeS Acquisition

In 2008 PAION acquired the company CeNeS Pharmaceuticals plc based in Cambridge, Great Britain. The drugs Remimazolam, M6G und Solulin derive from this transaction. 

News:

Ad hoc release: PAION AG completes acquisition of CeNeS

23 June 2008

press release: PAION AG completes acquisition of CeNeS

23 June 2008

Press release: Court sanctions Scheme of Arrangement for acquisition of CeNeS

20 June 2008

Regulatory release: AIM Prospective Admission

11 June 2008

Press release: Shareholders of CeNeS vote for acquisition by PAION

28 May 2008

Press release: PAION Annual General Meeting and CeNeS Acquisition Update

6 May 2008

Ad-hoc PAION AG intends to acquire CeNeS Pharmaceuticals plc

10 April 2008

press PAION AG intends to acquire CeNeS Pharmaceuticals plc

10 April 2008

Documents:

Prospectus:

PAION Prospectus for the Public Offer and Admission to Trading of up to 7,850,000 ordinary no-par value bearer shares

16.05.2008